Two months after Novartis announced changes to streamline its operations, all systems appear to be running smoothly as the Swiss pharma giant turned in another strong quarter fueled by double digit growth in key, branded products.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,